MDA Admin, Author at Muscular Dystrophy Association

Uncategorized

ReveraGen BioPharma Announces Start of Phase 1 Clinical Trial of VBP15 Dissociative Steroid Drug

MDA Admin 02/18/201508/10/2023

Product holds potential for replacing glucocorticoids in Duchenne muscular dystrophy and other chronic inflammatory states SILVER SPRING, M.D./ CHICAGO – February 18, 2015 – ReveraGen BioPharma today announced the start of a Phase 1, first-in-human, clinical trial of a novel dissociative steroidal drug, VBP15, under development for Duchenne muscular dystrophy. Recruitment in the trial is . . .

Uncategorized

Dear ALS Community

MDA Admin 02/02/201512/22/2015

Dear ALS Community, We are excited and enthusiastic about the new approaches and new drugs that are being tested for people with ALS and remain very hopeful that one or more of these will become a therapy with substantial impact on slowing down or perhaps even stopping ALS. We remain grateful to the brave volunteers . . .

Young Adults

Top Things to Consider When You Move

MDA Admin 01/20/201402/22/2017

Make sure you are fully informed while planning your move

First Previous...23 24 2526

Author: MDA Admin

ReveraGen BioPharma Announces Start of Phase 1 Clinical Trial of VBP15 Dissociative Steroid Drug

Dear ALS Community

Top Things to Consider When You Move

Connect with MDA

About MDA

Ways to Help

MDA Tools

Connect with MDA